Molecules 2014, 19
1313
was filtered off, washed with water and dried. It was then purified by flash column chromatography
(eluent: ethyl acetate/petroleum ether, 1:6 v/v) to afford the yellow solid product 2-((4-chloro-5-(4-
methoxyphenyl)-1-phenyl-1H-pyrazol-3-yl)oxy)-1-(2-thioxothiazolid-in-3-yl)ethanone (II). Yield: 65%;
1
M.p. 193–194 °C; H-NMR (500 MHz, CDCl3) δ: 7.26–7.15 (m, 7H, Ar-H), 6.88 (d, J = 8.8 Hz, 2H,
Ar-H), 5.78 (s, 2H, CH2), 4.61 (t, J = 7.6 Hz, 2H, CH2), 3.82 (s, 3H, OCH3), 3.38 (t, J = 7.6 Hz, 2H,
CH2); Anal. Calcd for C21H18ClN3O3S2: C 54.84, H 3.94, N 9.14; found C 54.95, H 3.95, N 9.17.
3.2.3. Preparation of Compound III
2-((5-(3-Chlorophenyl)-1-phenyl-1H-pyrazol-3-yl)oxy)acetic acid (0.33 g, 1.0 mmol) was dissolved
in a solution of DCC (0.22 g, 1.05 mmol) in CH2Cl2 (50 mL), and the mixture was stirred at 0 °C for 1 h.
Then, thiazolidine-2-thione (0.12 g, 1.0 mmol) and DMAP (0.01 g, 0.1 mmol) was added.
The solution was stirred at 0 °C for 2 h and then at room temperature for 12 h. The white precipitate
was filtered off and the solvent was evaporated under reduced pressure. The residue was purified by
flash column chromatography over silica gel eluting with petroleum ether/ethyl acetate 3:1 to gain the
the yellow solid product 2-((5-(3-chlorophenyl)-1-phenyl-1H-pyrazol-3-yl)oxy)-1-(2-thioxothiazolidin-
3-yl)ethanone (III). Yield: 73%; M.p. 143–144 °C; 1H-NMR (500 MHz, CDCl3) δ: 7.30–7.05 (m, 9H,
Ar-H), 6.05 (s, 1H, CH), 5.72 (s, 2H, CH2), 4.60 (t, J = 7.6 Hz, 2H, CH2), 3.37 (t, J = 7.6 Hz, 2H,
CH2); Anal. Calcd for C20H16ClN3O2S2: C 55.87, H 3.75, N 9.77; found C 55.78, H 3.74, N 9.80.
3.2.4. Preparation of Compound IV
A mixture of CHCl3 (20 mL), Bu4N+Br− (0.23 g, 0.7 mmol), and H2O (2 mL) was heated to 55 °C,
and then a solution of 1-(4-fluorophenyl)-5-(4-isopropylphenyl)-1H-pyrazol-3-ol (0.30 g, 1.0 mmol)
in CHCl3 (15 mL) and 5% aqueous NaOH (6 mL) were added dropwise. The pH value was adjusted
to 8–10, and acetobromo-α-D-glucose (0.54 g, 1.3 mmol) was added under vigorously stirring. The
mixture was stirred at 55 °C for another 4 h, and then left to cool to room temperature. The organic
layer was separated, washed with 5% aqueous NaOH, and dried. Then, the solvent was removed
in vacuo and the residue was recrystallized from ethanol to give the white solid product 3-(2′,3′,4′,
6′-tetra-O-acetyl-β-D-glucopyranosyloxy)-1-(4-isopropylphenyl)-5-(4-fluorophenyl)-1H-pyrazole (IV).
Yield: 46%; M.p. 151–152 °C. 1H-NMR (500 MHz, CDCl3) δ: 7.26–6.97 (m, 8H, Ar-H), 5.99 (s, 1H,
CH), 5.67 (d, J = 7.7 Hz, 1H, H1′), 5.32–5.26 (m, 2H, H2′, H3′), 5.19 (t, J = 9.5 Hz, 1H, H4′),
4.28 (dd, J = 4.7, 12.4 Hz, 1H, H6′b), 4.18 (dd, J = 2.4, 12.4 Hz, 1H, H6′a), 3.91–3.88 (m, 1H, H5′),
2.93–2.87 (m, 1H, CH), 2.05, 2.04, 2.03, 2.01 (4× s, 12H, 4× COCH3), 1.23 (d, J = 6.9 Hz, 6H, CH3);
Anal. Calcd for C32H35FN2O10: C 61.34, H 5.63, N 4.47; found C 61.52, H 5.61, N 4.45.
3.3. X-ray Crystallography
Suitable crystals of I–IV were obtained by slow evaporation of ethyl acetate solutions at r.t. Crystal
data were performed on a Nonius CAD-4 diffractometer (Enraf-Nonius, Rotterdam, The Netherlands)
by using MoKα (λ = 0.71073 Å) irradiation. All of the structures were solved by direct methods using
SHELXS-97 and refined by full-matrix least-squares on F2 for all data using SHELXL-97 [17]. All
non-H-atoms were refined anisotropically, and H-atoms were introduced at calculated positions. The